MoneyWorks4Me

The total revenue for the quarter ended December 2022 remained nearly unchanged at Rs. 573.83 millions.Profit after tax improved marginally to Rs. 41.45  millions for the quarter ended December 2022 from Rs. 40.13 millions of corresponding previous quarter.Operating Profit saw a handsome growth to 78.83 millions from 71.35 millions in the quarter ended December 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 573.83 572.26 0.27 1632.74 1614.32 1.14 2196.63 2448.05 -10.27
Other Income 19.78 22.35 -11.50 78.30 62.91 24.46 119.93 71.41 67.95
PBIDT 78.83 71.35 10.48 215.11 238.58 -9.84 314.56 449.80 -30.07
Interest 7.17 1.54 365.58 18.39 4.63 297.19 13.55 2.71 400.00
PBDT 71.66 69.81 2.65 196.72 234.30 -16.04 301.25 447.39 -32.67
Depreciation 12.01 9.92 21.07 33.71 29.37 14.78 39.48 40.35 -2.16
PBT 59.65 59.89 -0.40 163.01 204.93 -20.46 261.77 407.04 -35.69
TAX 18.20 19.76 -7.89 46.91 54.62 -14.12 63.86 115.32 -44.62
Deferred Tax 2.10 2.44 -13.93 6.31 2.50 152.40 1.40 2.31 -39.39
PAT 41.45 40.13 3.29 116.10 150.31 -22.76 197.91 291.72 -32.16
Equity 940.00 829.95 13.26 940.00 829.95 13.26 862.45 789.95 9.18
PBIDTM(%) 13.74 12.47 10.18 13.17 14.78 -10.85 14.32 18.37 -22.06
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..